Use of genomic signatures to predict response to histone deacetylase inhibitors and correlation with tumor subtypes and molecular pathways.

被引:1
作者
Cohen, A. L.
Soldi, R.
Bild, A.
机构
[1] Huntsman Canc Inst, Salt Lake City, UT USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.e13596
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13596
引用
收藏
页数:1
相关论文
empty
未找到相关数据